Halol plant

Sun Pharma has fared worse compared to its peers and the broad market. Graphic: Naveen Kumar Saini/Mint

Sun Pharma: One down, Halol to go

3 min read . 23 Mar 2018
Most companies reported a healthy recovery in domestic sales, as the market situation has turned more normal after the initial disruption caused by GST rollout. Photo: Hemant Mishra/ Mint

Pharma: stable but not improving

1 min read . 02 Mar 2018